IL-3 Is a Marker of Encephalitogenic T Cells, but Not Essential for CNS Autoimmunity

Identifying molecules that are differentially expressed in encephalitogenic T cells is critical to the development of novel and specific therapies for multiple sclerosis (MS). In this study, IL-3 was identified as a molecule highly expressed in encephalitogenic Th1 and Th17 cells, but not in myelin-specific non-encephalitogenic Th1 and Th17 cells. However, B10.PL IL-3-deficient mice remained susceptible to experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. Furthermore, B10.PL myelin-specific T cell receptor transgenic IL-3−/− Th1 and Th17 cells were capable of transferring EAE to wild-type mice. Antibody neutralization of IL-3 produced by encephalitogenic Th1 and Th17 cells failed to alter their ability to transfer EAE. Thus, IL-3 is highly expressed in myelin-specific T cells capable of inducing EAE compared to activated, non-encephalitogenic myelin-specific T cells. However, loss of IL-3 in encephalitogenic T cells does not reduce their pathogenicity, indicating that IL-3 is a marker of encephalitogenic T cells, but not a critical element in their pathogenic capacity.

[1]  Yuhong Yang,et al.  IL-23R-activated STAT3/STAT4 is essential for Th1/Th17-mediated CNS autoimmunity. , 2017, JCI insight.

[2]  C. Mitchell,et al.  Neuronal Release of Cytokine IL-3 Triggered by Mechanosensitive Autostimulation of the P2X7 Receptor Is Neuroprotective , 2016, Front. Cell. Neurosci..

[3]  K. Renner,et al.  IL-3 promotes the development of experimental autoimmune encephalitis. , 2016, JCI insight.

[4]  Yuhong Yang,et al.  Analysis of TGF-β1 and TGF-β3 as regulators of encephalitogenic Th17 cells: Implications for multiple sclerosis , 2015, Brain, Behavior, and Immunity.

[5]  R. Weissleder,et al.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis , 2015, Science.

[6]  J. C. Love,et al.  Functional inflammatory profiles distinguish myelin-reactive T cells from patients with multiple sclerosis , 2015, Science Translational Medicine.

[7]  A. Regev,et al.  Induction and molecular signature of pathogenic TH17 cells , 2012, Nature Immunology.

[8]  B. Becher,et al.  RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation , 2011, Nature Immunology.

[9]  F. Safavi,et al.  The encephalitogenicity of TH17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF , 2011, Nature Immunology.

[10]  Todd Davidson,et al.  Generation of Pathogenic Th17 Cells in the Absence of TGF-β Signaling , 2010, Nature.

[11]  A. Bothwell,et al.  Transforming growth factor β is dispensable for the molecular orchestration of Th17 cell differentiation , 2009, The Journal of experimental medicine.

[12]  Yuhong Yang,et al.  T-bet is essential for encephalitogenicity of both Th1 and Th17 cells , 2009, The Journal of experimental medicine.

[13]  Y. Talke,et al.  Important role of interleukin-3 in the early phase of collagen-induced arthritis. , 2009, Arthritis and rheumatism.

[14]  T. Brunner,et al.  IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils. , 2008, Blood.

[15]  D. Wraith,et al.  Cutting Edge: Th1 Cells Facilitate the Entry of Th17 Cells to the Central Nervous System during Experimental Autoimmune Encephalomyelitis1 , 2008, The Journal of Immunology.

[16]  Y. Talke,et al.  Basophils enhance immunological memory responses , 2008, Nature Immunology.

[17]  A. Lovett-racke,et al.  T-bet Regulates the Fate of Th1 and Th17 Lymphocytes in Autoimmunity1 , 2007, The Journal of Immunology.

[18]  E. Ponomarev,et al.  GM-CSF Production by Autoreactive T Cells Is Required for the Activation of Microglial Cells and the Onset of Experimental Autoimmune Encephalomyelitis1 , 2007, The Journal of Immunology.

[19]  E. Frohman,et al.  Multiple sclerosis--the plaque and its pathogenesis. , 2006, The New England journal of medicine.

[20]  P. Ott,et al.  The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice , 2005, Journal of Neuroimmunology.

[21]  A. Lovett-racke,et al.  Silencing T-bet defines a critical role in the differentiation of autoreactive T lymphocytes. , 2004, Immunity.

[22]  S. Szabo,et al.  Loss of T-bet, But Not STAT1, Prevents the Development of Experimental Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.

[23]  S. Sriram,et al.  Signaling through JAK2‐STAT5 pathway is essential for IL‐3‐induced activation of microglia , 2004, Glia.

[24]  J. McQualter,et al.  Granulocyte Macrophage Colony-Stimulating Factor A New Putative Therapeutic Target in Multiple Sclerosis , 2001 .

[25]  S. Baranzini,et al.  Transcriptional Analysis of Multiple Sclerosis Brain Lesions Reveals a Complex Pattern of Cytokine Expression1 , 2000, The Journal of Immunology.

[26]  J. Frelinger,et al.  Interleukin‐3 and granulocyte–macrophage colony‐stimulating factor enhance the generation and function of dendritic cells , 1999, Immunology.

[27]  A. Look,et al.  Two Distinct Interleukin-3-Mediated Signal Pathways, Ras-NFIL3 (E4BP4) and Bcl-xL, Regulate the Survival of Murine Pro-B Lymphocytes , 1999, Molecular and Cellular Biology.

[28]  J. Burns,et al.  Isolation of myelin basic protein–specific T cells predominantly from the memory T‐cell compartment in multiple sclerosis , 1999, Annals of neurology.

[29]  G. Dranoff,et al.  Role for interleukin-3 in mast-cell and basophil development and in immunity to parasites , 1998, Nature.

[30]  C. June,et al.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells. , 1998 .

[31]  M. Mihm,et al.  Involvement of interleukin-3 in delayed-type hypersensitivity. , 1998, Blood.

[32]  L. Gold,et al.  Macrophage/microglial-mediated primary demyelination and motor disease induced by the central nervous system production of interleukin-3 in transgenic mice. , 1996, The Journal of clinical investigation.

[33]  L. Hood,et al.  Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity , 1993, Cell.

[34]  J. Gamble,et al.  IL-3 and granulocyte-macrophage colony-stimulating factor stimulate two distinct phases of adhesion in human monocytes. , 1990, Journal of immunology.

[35]  R J Albertini,et al.  T cells responsive to myelin basic protein in patients with multiple sclerosis. , 1990, Science.

[36]  E. Dotsika,et al.  Interleukin-3 production as a sensitive measure of T-lymphocyte activation in the mouse. , 1987, Immunology.

[37]  M. Steinmetz,et al.  Interleukin-3 supports growth of mouse pre-B-cell clones in vitro , 1984, Nature.

[38]  R. Palacios,et al.  Distinct mechanisms may account for the growth-promoting activity of interleukin 3 on cells of lymphoid and myeloid origin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.